Suppression of in vivo IgE and tissue IL-4 mRNA induction by SDZ 280.636, a synthetic muramyl dipeptide derivative

Immunopharmacology

Volumn 36, Issue 1, 1997, Pages 27-39

  Kricek, Franz ^a   Zunic, Melita ^a   Ruf, Christine ^a   De Jong, Gerard ^a   Dukor, Peter ^a   Bahr, George M ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b Vacsyn SA   (France)

Author keywords

anti IgD model; cytokine gene expression; IgE regulation; muramyl peptides

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; MURAMYL DIPEPTIDE DERIVATIVE; SDZ 280636; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNOMODULATION; LYMPH NODE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PEYER PATCH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALS; DIPEPTIDES; FEMALE; GOATS; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; INTERLEUKIN-4; LYMPHOID TISSUE; MICE; MICE, INBRED BALB C; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0030905452     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(96)00151-8     Document Type: Article

References (29)

1. Auci DL, Chice SM, Heusser C, Athanassiades TJ, Durkin HG. Origin and fate of IgE-bearing lymphocytes II: Gut-associated lymphoid tissues as sites of first appearance of IgE-bearing B lymphocytes and hapten-specific IgE antibody-forming cells in mice immunized with benzylpenicillolyl-keyhole limpet hemo-cyanin by various routes - relation to asialo GM 1 ganglioside + cells and IgE/CD 23 immune complexes. J Immunol 1992; 149: 2241-2248.
2. Auci DL, Chice SM, Dukor P, Durkin HG. Control of IgE responses II. Isotype specific suppression of peak hapten specific IgE antibody forming cell responses in BPO-KLH sensitized mice after oral administration of muramyldipeptide or murabutide. Immunopharmacol 1993a; 26: 157-169.
3. Auci DL, Carucci JA, Chice SM, Smith MC, Dukor P, Durkin HG. Control of IgE responses 4. Isotype-specific suppression of peak BPO-specific IgE antibody-forming cell responses and of BPO-specific IgE in serum by muramyldipeptide or murabutide after administration to mice by gavage. Int Arch Allergy Immunol 1993b; 101: 167-176.
4. Bahr GM, Modabber FZ, Morin A, Terrier M, Eyquem A, Chedid L. Regulation by muramyl dipeptide (MDP) of the lymphoproliferative responses and polyclonal activation of human peripheral blood mononuclear cells. Clin Exp Immunol 1984; 57: 178-186.
5. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across lamellae of swollen phospholipides. J Mol Biol 1965; 13: 238-252.
6. Champion BR, Bucham S, Page K, Obray H, Zanders ED. Secondary immunoglobolin resoonses of BALB/c mice previously stimulated with goat anti-mouse IgD. Immunology 1991; 72: 336-343.
7. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
8. Coffman RL, Ohara J, Bond MW, Carty J, Zlotnick A, Paul WE. B cell stimulatory factor-1 enhances IgE response of lipopolysaccharide-activated B cells. J Immunol 1986; 136: 4538-4541.
9. Coffman RL, Seymour BWP, Lebmann DA, Hiraki DD, Christiansen JA, Shrader B, Cherwinski HM, Savelkoul HFJ, Finkelmann FD, Bond MW, Mosmann TR. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev 1988; 102: 5-28.
10. Durkin HG, Chice SM, Geatjens E, Bazin H, Tarcsay L, Dukor P. Origin and fate of IgE-bearing lymphocytes II. Modulation of IgE isotype expression on Peyer's patch cell wall components or by thymectomy. J Immunol 1989; 143: 1777-1783.
11. Finkelman FD, Scher I, Mond JJ, Kung JT, Metcalf ES. Polyclonal activation of the murine immune system by an antibody to IgD. I. Increase in cell size and DNA synthesis. J Immunol 1982; 129: 629-637.
12. Finkelman FD, Smith J, Villacreses N, Metcalf ES. Polyclonal activation of the murine immune system by an antibody to IgD VI. Influence of doses of goat anti-mouse 8 chain and normal goat IgG on B lymphocyte proliferation and differentiation. Eur J Immunol 1985; 15: 315-320.
13. Finkelman FD, Katona IM, Urban Jr. JF, Snapper CM, Ohara J, Paul WE. Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1. Proc Natl Acad Sci USA 1986; 83: 9675-9678.
14. Finkelman FD, Katona IM, Urban Jr. JF, Holmes J, Ohara J, Tung AS, Sample JG, Paul WE. IL-4 is required to generate and sustain in vivo IgE-responses. J Immunol 1988; 141: 2335-2341.
15. Finkelman FD, Holmes J, Urban Jr. JF, Paul WE, Katona IM. T help requirements for the generation of an in vivo IgE response: a late acting form of T cell help other than IL-4 is required for IgE but not for IgG1 production. J Immunol 1989; 142: 403-408.
16. Katona IM, Urban Jr. JF, Kang SS, Paul WE, Finkelman FD. IL-4 requirements for the generation of secondary in vivo IgE responses. J Immunol 1991; 146: 4215-4221.
17. Kricek F, Ruf C, Zunic M, De Jong G, Dukor P, Bahr GM. Induction in mice of serum IgE levels after treatment with anti mouse IgD antibodies is preceded by differential modulation of tissue cytokine gene transcription. Eur J Immunol 1995; 25: 936-941.
18. Lebman DA, Coffman RL. Interleukin 4 causes isotype switchig to IgE in T cell-stimulated clonal B cell cultures. J Exp Med 1988; 168: 853-862.
19. McKenzie ANJ, Culpepper JA, De Waal Malefyt R, Briere F, Punnonen J, Aversa G, Sato A, Dang W, Cocks BG, Menon S, De Vries JE, Banchereau J, Zuwarski G. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 1993; 90: 3735-3739.
20. Oppenheim JJ, Togawa A, Chedid L, Mizel S. Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor. Cell Immunol 1980; 50: 71-81.
21. Parant J, Chedid LA. Stimulation of non-specific resistance to infections by synthetic immunoregulatory agents. Infection 1984; 12: 230-234.
22. Pene J, Rousset F, Briere F, Chretien I, Bonnefoy JY, Spits J, Yokota T, Arai N, Bancherau J, De Vries J. IgE production by normal human lymphocytes is induced by interleukin 4 and supressed by interferons γ and α and prostaglandin E2. Proc Natl Acad Sci USA 1988; 85: 6880-6884.
23. Prouvost-Danon A, Bahr GM, Chedid L, Ekwalanga M, Bassot S. In vivo effects of ovalbumin-conjugated muramyl peptides on the anti-ovalbumin IgE and IgG responses in mice. Int J Immunopharm 1984; 6: 425-431.
24. Punnonen J, Aversa G, Cocks BG, McKenzie ANJ, Menon S, Zuwarski G, De Waal Malefyt R, De Vries JE. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression in human B cells. Proc Natl Acad Sci USA 1993; 90: 3730-3734.
25. Rothman PY, Chen I, Lutzker S, Li SC, Stuart V, Coffman R, Alt FW. Structure and expression of germline immunoglobin heavy-chain ε transcripts: interleukin 4 plus lipopolysaccharide-directed switching to Cε. Mol Cell Biol 1990; 10: 1672-1679.
26. Snapper CM, Finkelman FD, Paul WE. Differential regulation of IgGl and IgE synthesis by interleukin 4. J Exp Med 1988; 167: 183-196.
27. Svetic A, Finkelman FD, Jian YC, Dieffenbach C, Scott DE, McCarthy KF, Steinberg AD, Gause WC. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J Immunol 1991; 147: 2391-2397.
28. Svetic A, Madden KB, Di Zhou X, Lu P, Katona IM, Finkelman FD, Urban Jr. JF, Gause WC. A primary intestinal helminithic infection rapidly induces a gut-associated elevation of Th2-associated cytokines and IL-3. J Immunol 1993; 150: 3434-3441.
29. Zurawski G, De Vries JE. Interleukin 13, an Interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994; 15: 19-26.